Bundamedik Tbk Financials
| BMHS Stock | 268.00 2.00 0.74% |
Bundamedik |
Understanding current and past Bundamedik Tbk Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bundamedik Tbk's financial statements are interrelated, with each one affecting the others. For example, an increase in Bundamedik Tbk's assets may result in an increase in income on the income statement.
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000161201 |
| Business Address | Jl Teuku Cik |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Benchmark | Dow Jones Industrial |
| Website | www.bmhs.co.id |
| Phone | 62 21 3192 3344 |
You should never invest in Bundamedik Tbk without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bundamedik Stock, because this is throwing your money away. Analyzing the key information contained in Bundamedik Tbk's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bundamedik Tbk Key Financial Ratios
Bundamedik Tbk's financial ratios allow both analysts and investors to convert raw data from Bundamedik Tbk's financial statements into concise, actionable information that can be used to evaluate the performance of Bundamedik Tbk over time and compare it to other companies across industries.| Return On Equity | 0.0811 | |||
| Return On Asset | 0.0465 | |||
| Target Price | 855.0 | |||
| Z Score | 9.0 | |||
| Last Dividend Paid | 2.56 |
Bundamedik Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bundamedik Tbk's current stock value. Our valuation model uses many indicators to compare Bundamedik Tbk value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bundamedik Tbk competition to find correlations between indicators driving Bundamedik Tbk's intrinsic value. More Info.Bundamedik Tbk PT is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bundamedik Tbk PT is roughly 1.74 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bundamedik Tbk's earnings, one of the primary drivers of an investment's value.Bundamedik Tbk PT Systematic Risk
Bundamedik Tbk's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bundamedik Tbk volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Bundamedik Tbk PT correlated with the market. If Beta is less than 0 Bundamedik Tbk generally moves in the opposite direction as compared to the market. If Bundamedik Tbk Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bundamedik Tbk PT is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bundamedik Tbk is generally in the same direction as the market. If Beta > 1 Bundamedik Tbk moves generally in the same direction as, but more than the movement of the benchmark.
Bundamedik Tbk December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bundamedik Tbk help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bundamedik Tbk PT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bundamedik Tbk PT based on widely used predictive technical indicators. In general, we focus on analyzing Bundamedik Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bundamedik Tbk's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 10.93 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 2.21 |
Other Information on Investing in Bundamedik Stock
Bundamedik Tbk financial ratios help investors to determine whether Bundamedik Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bundamedik with respect to the benefits of owning Bundamedik Tbk security.